𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Malignant Pheochromocytomas and Paragangliomas : A Phase II Study of Therapy with High-Dose 131I-Metaiodobenzylguanidine (131I-MIBG)

✍ Scribed by PAUL A. FITZGERALD; ROBERT E. GOLDSBY; JOHN P. HUBERTY; DAVID C. PRICE; RANDALL A. HAWKINS; JANET J. VEATCH; FILEMON DELA CRUZ; THIERRY M. JAHAN; CHARLES A. LINKER; LLOYD DAMON; KATHERINE K. MATTHAY

Book ID
111479573
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
276 KB
Volume
1073
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

High-dose 131I-metaiodobenzylguanidine t
High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma
✍ Brian Rose; Katherine K. Matthay; David Price; John Huberty; Barbara Klencke; Je πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 112 KB

## Abstract ## BACKGROUND ^131^I‐Metaiodobenzylguanidine (^131^I‐MIBG) can be used systemically to treat malignant pheochromocytoma. To improve outcome, the authors used higher levels of activity of ^131^I‐MIBG than previously reported. The authors reported the response rates and toxicity levels i

Therapeutic use of131I-metaiodobenzylgua
Therapeutic use of131I-metaiodobenzylguanidine (MIBG) in neuroblastoma: A phase II study in nine patients
✍ Hartmann, O. ;Lumbroso, J. ;Lemerle, J. ;Schlumberger, M. ;Ricard, M. ;Aubert, B πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 576 KB

Effects of high activities of I 131 meta-iodobenzylguanidine (mIBG) were evaluated in nine children with advanced neuroblastoma. All patients had been previously heavily treated and had either primarily refractory disease or resistant relapse. Twenty-two doses of mIBG labeled with 1.3 to 4 GBq (35-1